Health Condition 1: N809- Endometriosis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: females diagnosed with endometriosis with or without pelvic pain or secondary dysmenorrhea heavy menstrual bleeding patients willing to participate in the trail by signing informed consent
Exclusion criteria
Exclusion criteria: congenital malformation of the genital tract pelvic malignancy bleeding disorders severe anaemia hb less than 8 gm thrombocytopenia lactation first 6 months uncontrolled diabetes uncontrolled hypertension uncontrolled thyroid function
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in pain intensity assessed by visual analog scaleTimepoint: baseline 4 weeks 8 weeks 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| overall reduction in severity of dysmenorrhea and associated symtoms assessed by WaLIDD score SF 12 QOL questionnaire will be used to assess the intensity of pain and quality of life changes in usg for the size of endometriotic lesionTimepoint: baseline 12 weeks | — |
Countries
India
Contacts
National Institute of Unani Medicine